Forlong

Forlong is an innovative R&D company driven by synthetic immunology technology, focusing on the development of protein drugs such as cytokines. Backed by an internationally renowned protein drug discovery laboratory, the founding team possesses deep scientific research conversion capabilities, and the core team has decades of experience in innovative drug development with extensive industrialization expertise. The company has established an internationally leading integrated synthetic immunology technology system, giving rise to four core technology platforms: the F-body long-acting technology platform, the artificial synthesis of novel cytokine platform, the Fc engineering platform, and the biomolecular artificial evolution platform. These four core technologies enable multi-dimensional optimization of protein drugs represented by cytokines, delivering superior products. The preclinical data of Forlong’s leading pipeline, FL115 (IL-15), shows significantly better safety and efficacy compared to representative products in the field.